- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07153471
- Original Trial
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee (ATTAIN-OA PAIN)
May 20, 2026 updated by: Eli Lilly and Company
A Phase 3 Study to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee: A Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Trial
The GZPT master protocol will support two independent studies, J2A-MC-GZT1 and J2A-MC-GZT2.
Each study will see how well and safely orforglipron works in people with obesity or overweight who have osteoarthritis (OA) of the knee with pain.
Participation in the study will last about 74 weeks.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
800
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
- Phone Number: 1-317-615-4559
- Email: LillyTrials@Lilly.com
Study Contact Backup
- Name: Physicians interested in becoming principal investigators please contact
- Email: clinical_inquiry_hub@lilly.com
Study Locations
-
-
-
Brampton, Canada, L6T 0G1
- Recruiting
- Aggarwal and Associates Limited
-
Contact:
- Phone Number: 9054589033
-
Principal Investigator:
- Naresh Aggarwal
-
Joliette, Canada, J6E 6A9
- Recruiting
- Diex Recherche Inc. Division Joliette
-
Principal Investigator:
- Jean-Sebastien Paquette
-
Contact:
- Phone Number: 450-755-2525
-
Niagara Falls, Canada, L2H 1H5
- Recruiting
- Your Research Network
-
Principal Investigator:
- Mondeesh Sidhu
-
Québec, Canada, G3K 2P8
- Recruiting
- ALPHA Recherche Clinique
-
Principal Investigator:
- Xavier Mignault
-
Contact:
- Phone Number: 418-847-1112
-
Québec, Canada, G2J 0C4
- Recruiting
- ALPHA Recherche Clinique
-
Principal Investigator:
- Nancy Labrecque
-
Québec, Canada, G1V 3M7
- Recruiting
- G.R.M.O. (Groupe de recherche en maladies osseuses) Inc.
-
Principal Investigator:
- Louis Bessette
-
Contact:
- Phone Number: 418 650-2661
-
Sarnia, Canada, N7T 4X3
- Recruiting
- Bluewater Clinical Research Group Inc.
-
Principal Investigator:
- John O'Mahony
-
Contact:
- Phone Number: 1 (519) 344-6612
-
Stoney Creek, Canada, L8J 0B6
- Recruiting
- Winterberry Research Inc.
-
Principal Investigator:
- Steven Zizzo
-
Contact:
- Phone Number: 365-366-6267
-
Victoria, Canada, V8V 4A1
- Not yet recruiting
- Dr. M.B. Jones Inc.
-
Principal Investigator:
- Michael Jones
-
Contact:
- Phone Number: 2503833311
-
-
-
-
-
Baotou, China, 014010
- Recruiting
- The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technolo -T
-
Principal Investigator:
- Yongfu Wang
-
Contact:
- Phone Number: 8618047211500
-
Beijing, China, 100053
- Recruiting
- Xuanwu Hospital Capital Medical University
-
Principal Investigator:
- Yi Zhao
-
Chongqing, China, 400010
- Recruiting
- The Second Affiliated Hospital Chongqing Medical University
-
Principal Investigator:
- Lin Tang
-
Contact:
- Phone Number: 02363693222
-
Harbin, China, 150001
- Recruiting
- The Fourth Affiliated Hospital of Harbin Medical University
-
Contact:
- Phone Number: 18903602198
-
Principal Investigator:
- ZhiFeng Cheng
-
Hefei, China, 230011
- Recruiting
- The Second People's hospital of Hefei
-
Principal Investigator:
- Jun Ye
-
Contact:
- Phone Number: 86-13956099720
-
Jinan, China, 250013
- Recruiting
- Jinan Central Hospital
-
Contact:
- Phone Number: 15318816130
-
Principal Investigator:
- Shuya Guo
-
Luoyang, China, 471003
- Recruiting
- The First Affiliated Hospital of Henan University of Science &Technology
-
Principal Investigator:
- Xiaofei Shi
-
Contact:
- Phone Number: 86 13663884080
-
Nanjing, China, 210029
- Recruiting
- Jiangsu Province Hospital
-
Principal Investigator:
- Wenfeng Tan
-
Nanjing, China, 211100
- Recruiting
- Nanjing Medical University - Nanjing Jiangning Hospital
-
Principal Investigator:
- Kun Wang
-
Contact:
- Phone Number: 025-52105625
-
Pingxiang, China, 337055
- Recruiting
- Pingxiang People's Hospital
-
Contact:
- Phone Number: 13879936380
-
Principal Investigator:
- Jiankang Hu
-
Qinhuangdao Shi, China, 066000
- Not yet recruiting
- The First Hospital of Qinhuangdao
-
Principal Investigator:
- Bowei Liu
-
Contact:
- Phone Number: 15903366689
-
Shanghai, China, 200040
- Recruiting
- Huashan Hospital, Fudan University
-
Principal Investigator:
- Weiguo Wan
-
Contact:
- Phone Number: 18121186085
-
Shantou, China, 515041
- Recruiting
- The First Affiliated Hospital of Shantou University Medical College
-
Contact:
- Phone Number: 13750428653
-
Principal Investigator:
- Zhiduo Hou
-
Shenzhen, China, 518053
- Recruiting
- The University of Hong Kong-Shenzhen Hospital
-
Principal Investigator:
- Ling Wu
-
Taizhou, China, 317000
- Not yet recruiting
- Taizhou Hospital of Zhejiang Province
-
Principal Investigator:
- Zhenghua Hong
-
-
-
-
-
Berlin, Germany, 10117
- Not yet recruiting
- Klinische Forschung Berlin-Mitte
-
Contact:
- Phone Number: +49 30 206 580 800
-
Principal Investigator:
- Hartmut Tischner
-
Bochum, Germany, 44787
- Recruiting
- Siteworks GmbH - Bochum
-
Contact:
- Phone Number: +49 234 60144350
-
Principal Investigator:
- Annemone Koechel
-
Dresden, Germany, 01069
- Recruiting
- Klinische Forschung Dresden
-
Principal Investigator:
- Peter Heymer
-
Contact:
- Phone Number: 00493512052780
-
Hamburg, Germany, 20253
- Recruiting
- Klinische Forschung Hamburg
-
Contact:
- Phone Number: 00494046076323
-
Principal Investigator:
- Marret Mehrwald
-
Hamburg, Germany, 20095
- Recruiting
- HRF II - Hamburger Rheuma Forschungszentrum II MVZ für Rheumatologie und Autoimmunmedizin Hamburg GmbH / -T
-
Principal Investigator:
- Andrea Everding
-
Contact:
- Phone Number: 004940323103166
-
Hanover, Germany, 30159
- Recruiting
- Klinische Forschung Hannover-Mitte
-
Principal Investigator:
- Jan Wagner
-
Contact:
- Phone Number: +49 511 169 76 50
-
Hanover, Germany, 30449
- Recruiting
- Siteworks GmbH - Hannover
-
Contact:
- Phone Number: +4951151524747
-
Principal Investigator:
- Ulrike Lengler
-
Karlsruhe, Germany, 76137
- Recruiting
- Klinische Forschung Karlsruhe
-
Principal Investigator:
- Alla Reimer
-
Contact:
- Phone Number: 0049 721 89 34 926
-
Karlsruhe, Germany, 76137
- Recruiting
- Siteworks - Karlsruhe
-
Contact:
- Phone Number: 004951151524740
-
Principal Investigator:
- Niels-Christian Hoellger
-
Leipzig, Germany, 04107
- Recruiting
- AmBeNet GmbH
-
Contact:
- Phone Number: 4934196276326
-
Principal Investigator:
- Hans-Detlev Stahl
-
München, Germany, 80809
- Recruiting
- CDG Studienambulanz Hartard
-
Principal Investigator:
- Manfred Hartard
-
Contact:
- Phone Number: 00498935819977
-
Offenbach, Germany, 63065
- Recruiting
- Dedicated Research Site FutureMeds
-
Principal Investigator:
- Christel Contzen
-
Contact:
- Phone Number: 0049 69 247433849
-
Rendsburg, Germany, 24768
- Recruiting
- Private Practice - Dr. Jochen Walter
-
Contact:
- Phone Number: 00494331337660
-
Principal Investigator:
- Jochen Walter
-
Würzburg, Germany, 97074
- Recruiting
- Universitaetsklinikum Wuerzburg
-
Contact:
- Phone Number: 00499318033575
-
Principal Investigator:
- Lothar Seefried
-
-
-
-
-
Bhubaneswar, India, 751019
- Not yet recruiting
- All India Institute of Medical Sciences
-
Contact:
- Phone Number: 9437182313
-
Principal Investigator:
- Bishnu Patro
-
Chennai, India, 600003
- Not yet recruiting
- Rajiv Gandhi Government General Hospital
-
Principal Investigator:
- Dr.Senthil Kumar Siva kumar
-
Kanpur, India, 208011
- Not yet recruiting
- Atmaram Child Care
-
Principal Investigator:
- Manish Singh
-
Nagpur, India, 440001
- Not yet recruiting
- Kims Kingsway Hospital
-
Principal Investigator:
- Mukesh Sancheti
-
New Delhi, India, 110002
- Not yet recruiting
- Maulana Azad Medical College and Associated with Lok Nayak Hospital
-
Principal Investigator:
- Sumit Arora
-
Pimpri-Chinchwad, India, 411027
- Not yet recruiting
- Vencer Hospital
-
Principal Investigator:
- Bhushan Shitole
-
-
-
-
-
Fukuoka, Japan, 811-0213
- Recruiting
- Fukuoka Wajiro Hospital
-
Contact:
- Phone Number: 81120023812
-
Principal Investigator:
- Daiki Okazaki
-
Fukuoka, Japan, 810-8539
- Recruiting
- Hamanomachi Hospital
-
Contact:
- Phone Number: 81120023812
-
Principal Investigator:
- Taro Mawatari
-
Izumo, Japan, 693-8501
- Recruiting
- Shimane University Hospital
-
Contact:
- Phone Number: 81120023812
-
Principal Investigator:
- Yuji Uchio
-
Kariya, Japan, 448-8505
- Recruiting
- Kariya Toyota General Hospital
-
Contact:
- Phone Number: 81120023812
-
Principal Investigator:
- Koji Funahashi
-
Kawasaki, Japan, 213-0001
- Recruiting
- Ando Orthopedic
-
Contact:
- Phone Number: 81120023812
-
Principal Investigator:
- Masayo Kato
-
Minatoku, Japan, 108-0073
- Recruiting
- Tokyo Saiseikai Central Hospital
-
Contact:
- Phone Number: 81120023812
-
Principal Investigator:
- Eri Katsuyama
-
Miyazaki, Japan, 880-0835
- Recruiting
- Goto Orthopedic Surgery Clinic
-
Contact:
- Phone Number: 81120023812
-
Principal Investigator:
- Keisuke Goto
-
Morioka, Japan, 020-0021
- Recruiting
- Kato Orthopedic Clinic
-
Contact:
- Phone Number: 81120023812
-
Principal Investigator:
- SADAFUMI KATO
-
Saitama, Japan, 330-0074
- Recruiting
- Japan Community Health Care Organization - Saitama Medical Center
-
Contact:
- Phone Number: 81120023812
-
Principal Investigator:
- Takao Kodama
-
Sapporo, Japan, 060-0007
- Recruiting
- Sapporo Maruyama Orthopedic Hospital
-
Contact:
- Phone Number: 81120023812
-
Principal Investigator:
- Miki Kuroda
-
Suginami City, Japan, 167-0051
- Recruiting
- Masumoto Orthopedics Clinic
-
Contact:
- Phone Number: 81120023812
-
Principal Investigator:
- Kou Masumoto
-
-
-
-
-
Chihuahua City, Mexico, 31000
- Recruiting
- Investigacion y Biomedicina de Chihuahua
-
Contact:
- Phone Number: 526144373003
-
Principal Investigator:
- Cesar Pacheco-Tena
-
Ciudad Madero, Mexico, 89440
- Recruiting
- Centro de Estudios de Investigacion Metabolicos y Cardiovasculares, S.C.
-
Principal Investigator:
- Rafael Violante Ortiz
-
Contact:
- Phone Number: 52 1 833 126 00 55
-
Mexicali, Mexico, 21100
- Recruiting
- Centro Medico del Angel
-
Contact:
- Phone Number: 6862262882
-
Principal Investigator:
- Beatriz Zazueta Montiel
-
Monterrey, Mexico, 64610
- Recruiting
- Clínica García Flores SC
-
Contact:
- Phone Number: 528113578379
-
Principal Investigator:
- Pedro García Hernández
-
Monterrey, Mexico, 64020
- Recruiting
- IMED Internal Medicine Clin Trials
-
Contact:
- Phone Number: 8183470078
-
Principal Investigator:
- Jose Garza Ruiz
-
Mérida, Mexico, 97070
- Recruiting
- Köhler & Milstein Research S.A. de C.V.
-
Principal Investigator:
- Jesus Simon Campos
-
Contact:
- Phone Number: +529999204004
-
-
-
-
-
A Coruña, Spain, 15006
- Recruiting
- Hospital San Rafael - La Coruña
-
Contact:
- Phone Number: 655624017
-
Principal Investigator:
- Alfonso Soto Gonzalez
-
Barcelona, Spain, 08035
- Recruiting
- Hospital Universitari Vall d'Hebron
-
Contact:
- Phone Number: 34697817352
-
Principal Investigator:
- ANDREEA CIUDIN
-
Málaga, Spain, 29004
- Recruiting
- Hospital Quirón Málaga
-
Contact:
- Phone Number: 34684054019
-
Principal Investigator:
- Jose Garcia Almeida
-
Santander, Spain, 39008
- Recruiting
- Hospital Universitario Marqués de Valdecilla
-
Contact:
- Phone Number: 34639659866
-
Principal Investigator:
- Luis Vazquez Salvi
-
Santiago de Compostela, Spain, 15702
- Recruiting
- Clínica Gaias - Santiago
-
Contact:
- Phone Number: 0034981951018
-
Principal Investigator:
- Juan Amarelo Ramos
-
Seville, Spain, 41003
- Recruiting
- Clínica nuevas Tecnologías en Diabetes y Endocrinología (NTDE)
-
Principal Investigator:
- Alberto Aliaga Verdugo
-
Contact:
- Phone Number: + 34 954709183
-
Seville, Spain, 41010
- Recruiting
- Hospital Quiron Infanta Luisa
-
Contact:
- Phone Number: 670502836
-
Principal Investigator:
- MARGARITA RIVAS FERNANDEZ
-
Valladolid, Spain, 47010
- Recruiting
- Hospital Clinico Universitario de Valladolid
-
Principal Investigator:
- Daniel De luis roman
-
Contact:
- Phone Number: 983420000 ext. 86660
-
-
-
-
Arizona
-
Phoenix, Arizona, United States, 85053
- Recruiting
- Arizona Research Center
-
Contact:
- Phone Number: 602-863-6363
-
Principal Investigator:
- Louise Taber MD
-
Tempe, Arizona, United States, 85281
- Recruiting
- AMR Clinical
-
Contact:
- Phone Number: 602-910-3343
-
Principal Investigator:
- William Reedy
-
-
California
-
Huntington Beach, California, United States, 92648
- Recruiting
- Care Access - Huntington Beach
-
Contact:
- Phone Number: 714-378-2440
-
Principal Investigator:
- Christine Thai
-
Thousand Oaks, California, United States, 91360
- Recruiting
- Care Access - Thousand Oaks
-
Principal Investigator:
- Elvira Lindwall
-
Contact:
- Phone Number: 805-778-5143
-
-
Colorado
-
Colorado Springs, Colorado, United States, 80909
- Recruiting
- Legacy Clinical Trials
-
Contact:
- Phone Number: 719-387-7572
-
Principal Investigator:
- Charles Bird
-
-
Connecticut
-
Waterbury, Connecticut, United States, 06708
- Recruiting
- Chase Medical Research, LLC
-
Contact:
- Phone Number: 203-419-4420
-
Principal Investigator:
- Joseph Soufer
-
-
Georgia
-
Decatur, Georgia, United States, 30030
- Recruiting
- Care Access - Decatur
-
Principal Investigator:
- Marie Walton
-
Contact:
- Phone Number: 678-470-4394
-
Woodstock, Georgia, United States, 30189
- Recruiting
- North Georgia Clinical Research
-
Contact:
- Phone Number: 678-494-5735
-
Principal Investigator:
- Bram Wieskopf
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Recruiting
- Northwestern University
-
Contact:
- Phone Number: 312-503-2315
-
Principal Investigator:
- Thomas Schnitzer
-
-
Kansas
-
Newton, Kansas, United States, 67114
- Recruiting
- AMR Clinical
-
Contact:
- Phone Number: 316-804-7304
-
Principal Investigator:
- Troy Holdeman
-
-
Massachusetts
-
Waltham, Massachusetts, United States, 02451
- Recruiting
- MedVadis Research Corporation
-
Contact:
- Phone Number: 617-744-1310
-
Principal Investigator:
- David DiBenedetto
-
-
Missouri
-
City of Saint Peters, Missouri, United States, 63303
- Recruiting
- StudyMetrix Research
-
Contact:
- Phone Number: 636-387-5100
-
Principal Investigator:
- Timothy Smith
-
Kansas City, Missouri, United States, 64114
- Recruiting
- AMR Clinical
-
Principal Investigator:
- Martha Fanning
-
-
New Jersey
-
Somerset, New Jersey, United States, 08873
- Recruiting
- Cardio Metabolic Institute
-
Principal Investigator:
- Dinesh Singal
-
Contact:
- Phone Number: 732-846-7000 x 108
-
-
North Carolina
-
Shelby, North Carolina, United States, 28150
- Recruiting
- Carolina Research Center
-
Principal Investigator:
- Stephen Jones
-
Contact:
- Phone Number: 704-600-6052
-
-
Pennsylvania
-
Altoona, Pennsylvania, United States, 16602
- Recruiting
- University Orthopedics Center
-
Principal Investigator:
- Joshua Greenleaf
-
-
South Dakota
-
Rapid City, South Dakota, United States, 57701
- Recruiting
- Care Access - Rapid City
-
Principal Investigator:
- Ali Bajwa
-
Contact:
- Phone Number: 877-791-0656
-
-
Tennessee
-
Knoxville, Tennessee, United States, 37909
- Recruiting
- AMR Clinical
-
Contact:
- Phone Number: 865-305-9100
-
Principal Investigator:
- Jerry Punch
-
-
Texas
-
Dallas, Texas, United States, 75208
- Recruiting
- Mercy Family Clinic
-
Contact:
- Phone Number: 281-944-3610
-
Principal Investigator:
- Ebere Israel Azubuike, MD
-
Houston, Texas, United States, 77084
- Recruiting
- Biopharma Informatic, LLC
-
Contact:
- Phone Number: 281-944-3610
-
Principal Investigator:
- Kiran Farheen, MD
-
Houston, Texas, United States, 77040
- Recruiting
- Juno Research
-
Contact:
- Phone Number: 713-779-5494
-
Principal Investigator:
- Damaris Vega
-
Kingwood, Texas, United States, 77339
- Recruiting
- Activian Clinical Research
-
Principal Investigator:
- Martin Basaldua
-
Contact:
- Phone Number: 832-969-3401
-
The Woodlands, Texas, United States, 77382
- Recruiting
- Advanced Rheumatology of Houston - Woodlands
-
Principal Investigator:
- Tamar Brionez
-
Contact:
- Phone Number: 936-681-4882
-
-
Virginia
-
Charlottesville, Virginia, United States, 22911
- Recruiting
- Charlottesville Medical Research
-
Contact:
- Phone Number: 434-817-2442
-
Principal Investigator:
- James Clark
-
Virginia Beach, Virginia, United States, 23454
- Recruiting
- Gershon Pain Specialists
-
Contact:
- Phone Number: 757-496-2050
-
Principal Investigator:
- Steven Gershon
-
-
Washington
-
Bellevue, Washington, United States, 98007
- Recruiting
- Northwest Clinical Research Center
-
Principal Investigator:
- Jeena Vaid
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Have a body mass index (BMI) of 27 kilograms per square meter (kg/m2) or higher at screening
- Have tried at least once to lose weight through diet but were unsuccessful
Have osteoarthritis of the knee and at least one of the following conditions:
- Be over 50 years old
- Have morning knee stiffness that lasts about 30 minutes
- Have a crackling or grinding sound or feeling in the knee
Exclusion Criteria:
- Have gained or lost more than 11 pounds within 90 days prior to screening
- Have had a surgery for obesity or plan to have one in the next 18 months
- Have an active knee infection
- Have type 1 diabetes, type 2 diabetes, or any other type of diabetes
- Have had a recent heart condition or New York Heart Association Functional Classification Class IV congestive heart failure
- Have used any glucagon-like peptide-1 (GLP-1) receptor agonist medication within 180 days of screening
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Orforglipron (GZT1)
Participants will receive orforglipron orally
|
Administered orally
Other Names:
|
|
Placebo Comparator: Placebo (GZT1)
Participants will receive placebo orally
|
Administered orally
|
|
Experimental: Orforglipron (GZT2)
Participants will receive orforglipron orally
|
Administered orally
Other Names:
|
|
Placebo Comparator: Placebo (GZT2)
Participants will receive placebo orally
|
Administered orally
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change from Baseline in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale Score
Time Frame: Baseline, Week 72
|
Baseline, Week 72
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percent Change from Baseline in Body Weight
Time Frame: Baseline, Week 72
|
Baseline, Week 72
|
|
|
Change from Baseline in Waist Circumference
Time Frame: Baseline, Week 72
|
Baseline, Week 72
|
|
|
Percent Change from Baseline in Total Cholesterol
Time Frame: Baseline, Week 72
|
Baseline, Week 72
|
|
|
Change from Baseline in the WOMAC Physical Function Subscale Score
Time Frame: Baseline, Week 72
|
Baseline, Week 72
|
|
|
Change from Baseline in 36-item, Short-Form Health Survey, version 2 (SF-36v2) Acute Form Physical Functioning Domain Score
Time Frame: Baseline, Week 72
|
Baseline, Week 72
|
|
|
Change from Baseline in Distance Walked During the 6-Minute Walk Test
Time Frame: Baseline, Week 72
|
Baseline, Week 72
|
|
|
Percent Change from Baseline in High-Sensitivity, C-reactive Protein (hsCRP)
Time Frame: Baseline, Week 72
|
Baseline, Week 72
|
|
|
Percent Change from Baseline in Tumor Necrosis Factor (TNF)-Alpha
Time Frame: Baseline, Week 72
|
Baseline, Week 72
|
|
|
Change from Baseline in WOMAC Stiffness Subscale
Time Frame: Baseline, Week 72
|
Baseline, Week 72
|
|
|
Change from Baseline in WOMAC Total Score
Time Frame: Baseline, Week 72
|
Baseline, Week 72
|
|
|
Change from Baseline in SF-36v2 Acute Form Domain Scores
Time Frame: Baseline, Week 72
|
With exception of the Physical Functioning Domain Score
|
Baseline, Week 72
|
|
Percentage of Participants Who Achieve Improved Categorical Shift in Patient Global Impression of Severity (PGIS) - Target Knee Function
Time Frame: Baseline, Week 72
|
Baseline, Week 72
|
|
|
Percentage of Participants Who Achieve Improved Categorical Shift in PGIS - Target Knee Pain
Time Frame: Baseline, Week 72
|
Baseline, Week 72
|
|
|
Change from Baseline in Average Pain Intensity Numeric Rating Scale (API-NRS) Score
Time Frame: Baseline, Week 72
|
Baseline, Week 72
|
|
|
Change from Baseline in Worst Pain Intensity Numeric Rating Scale (WPI-NRS) Score
Time Frame: Baseline, Week 72
|
Baseline, Week 72
|
|
|
Number of Participants with Allowed Concomitant Pain Medication
Time Frame: Baseline, Week 72
|
Baseline, Week 72
|
|
|
Pharmacokinetics (PK): Steady-State Area Under the Curve (AUC) of Orforglipron
Time Frame: Predose through Week 48
|
Predose through Week 48
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 15, 2025
Primary Completion (Estimated)
April 1, 2028
Study Completion (Estimated)
May 1, 2028
Study Registration Dates
First Submitted
September 2, 2025
First Submitted That Met QC Criteria
September 2, 2025
First Posted (Actual)
September 4, 2025
Study Record Updates
Last Update Posted (Actual)
May 22, 2026
Last Update Submitted That Met QC Criteria
May 20, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Rheumatic Diseases
- Body Weight
- Overweight
- Pathological Conditions, Signs and Symptoms
- Nutritional and Metabolic Diseases
- Signs and Symptoms
- Arthritis
- Joint Diseases
- Obesity
- Osteoarthritis
- Musculoskeletal Diseases
- Nutrition Disorders
- Overnutrition
- Substandard Drugs
- Pharmaceutical Preparations
- orforglipron
Other Study ID Numbers
- 27633
- 2025-522631-34-00 (Ctis)
- J2A-MC-GZPT (Other Identifier: Eli Lilly and Company)
- J2A-MC-GZT1 (Other Identifier: Eli Lilly and Company)
- J2A-MC-GZT2 (Other Identifier: Eli Lilly and Company)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Anonymized individual patient level data will be provided in a secure access environment upon approval of a research proposal and a signed data sharing agreement.
IPD Sharing Time Frame
Data are available 6 months after the primary publication or approval of the indication studied in the US and EU, whichever is later.
Data will be indefinitely available for requesting.
IPD Sharing Access Criteria
A research proposal must be approved by an independent review panel and researchers must sign a data sharing agreement.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis
-
Hacettepe UniversityNot yet recruitingThumb Osteoarthritis | Trapeziometacarpal Osteoarthritis | Carpometacarpal Osteoarthritis | Thumb Basal Joint OsteoarthritisTurkey (Türkiye)
-
Sanford HealthTerminatedKnee Osteoarthritis | Hip Osteoarthritis | Shoulder Osteoarthritis | Ankle Osteoarthritis | Wrist OsteoarthritisUnited States
-
Edin MešanovićCompletedOsteoarthritis | Osteoarthritis of the Knee | Osteoarthritis of Knee | Osteoarthritis of the Knees | Osteoarthritis (OA) of the Knee | Osteoarthritis Knee | Osteoarthritis in the Knee | Osteoarthritis of Knee JointBosnia and Herzegovina
-
Hospital for Special Surgery, New YorkRoyal Infirmary of EdinburghRecruitingKnee Osteoarthritis | Hip Osteoarthritis | Shoulder OsteoarthritisUnited States, United Kingdom
-
Middlesex UniversityRecruitingOsteoarthritis | Osteoarthritis (OA) | Osteoarthritis (OA) of the Knee | Osteoarthritis (OA) of the HipUnited Kingdom
-
Golden Jubilee National HospitalJohnson & Johnson; DePuy OrthopaedicsNot yet recruitingOsteoarthritis | Knee Osteoarthritis | Osteoarthritis (OA) | Osteo Arthritis | Osteoarthritis in the Knee | Osteoarthritis (Knee) | Osteo Arthritis of the KneeUnited Kingdom
-
University of EdinburghHospital for Special Surgery, New YorkActive, not recruitingKnee Osteoarthritis | Hip Osteoarthritis | Shoulder OsteoarthritisUnited Kingdom
-
Medical University of WarsawUnknownOsteoarthritis | Knee Osteoarthritis | Hip Osteoarthritis | Glenohumeral OsteoarthritisPoland
-
Medical University of WarsawUnknownOsteoarthritis | Knee Osteoarthritis | Hip Osteoarthritis | Glenohumeral OsteoarthritisPoland
-
Istanbul University - CerrahpasaCompletedKnee Osteoarthritis | Knee Osteoarthritis (Knee OA)Turkey (Türkiye)
Clinical Trials on Placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AkesoNot yet recruitingAtopic DermatitisChina
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
Chong Kun Dang PharmaceuticalUnknownHypertension | DyslipidemiasKorea, Republic of